Q4 2021 Holdings
Filed 2022-02-14 | 28 holdings | $183.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $84.8M | 2,095,231 | 46.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $29.5M | 1,767,486 | 16.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $29.4M | 761,398 | 16.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $14.7M | 178,500 | 8.0% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $11.1M | 702,623 | 6.1% |
| Cytek Biosciences Inc(CTKB) | COM | 23285D109 | $6.5M | 400,000 | 3.6% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $5.9M | 982,753 | 3.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $761.0K | 240,000 | 0.4% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $95.5K | 2,020,911 | 0.1% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $49.7K | 1,049,691 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $34.0K | 1,551,070 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $21.0K | 450,776 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $19.9K | 340,214 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $18.8K | 783,769 | 0.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $17.9K | 670,940 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $17.1K | 1,513,138 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $10.6K | 446,641 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $8.2K | 500,000 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $7.9K | 200,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $6.9K | 583,649 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.9K | 572,862 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $4.0K | 400,000 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $3.1K | 150,000 | 0.0% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $3.0K | 336,868 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $2.9K | 300,000 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $2.2K | 231,417 | 0.0% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $2.0K | 176,470 | 0.0% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $1.4K | 279,921 | 0.0% |